Sveinung Wergeland Sørbye (Sveinung W Sørbye)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 21

Top Topics

Cervical Cancer Screening

Top Venues

International journal of environmental research and public health

Pathogens (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Carlos Eduardo Aranda Flores, Bente Marie Falang, Laura Gómez-Laguna, Guillermo Gómez Gutiérrez, Jorge Miguel Ortiz León, Miguel Uribe, Omar Cruz, Sveinung Wergeland Sørbye
Enhancing Cervical Cancer Screening with 7-Type HPV mRNA E6/E7 Testing on Self-Collected Samples: Multicentric Insights from Mexico. Cancers 16 (13) (2024)
Marte Pettersen Mikalsen, Gunnar Skov Simonsen, Sveinung Wergeland Sørbye
Impact of HPV Vaccination on the Incidence of High-Grade Cervical Intraepithelial Neoplasia (CIN2+) in Women Aged 20-25 in the Northern Part of Norway: A 15-Year Study. Vaccines 12 (4) (2024)
Carlos Eduardo Aranda Flores, Bente Marie Falang, Laura Gómez-Laguna, Guillermo Gómez Gutiérrez, Jorge Miguel Ortiz León, Miguel Uribe, Omar Cruz, Sveinung Wergeland Sørbye
Enhancing Cervical Cancer Screening with 7-Type HPV mRNA E6/E7 Testing on Self-Collected Samples: Multicentric Insights from Mexico. Cancers 16 (13) (2024)
Marie Rykkelid, Helga Marie Wennberg, Elin Richardsen, Sveinung Wergeland Sørbye
Post-Conization HPV Vaccination and Its Impact on Viral Status: A Retrospective Cohort Study in Troms and Finnmark, 2022. Pathogens (Basel, Switzerland) 13 (5) (2024)
Marie Rykkelid, Helga Marie Wennberg, Elin Richardsen, Sveinung Wergeland Sørbye
Post-Conization HPV Vaccination and Its Impact on Viral Status: A Retrospective Cohort Study in Troms and Finnmark, 2022. Pathogens (Basel, Switzerland) 13 (5) (2024)
Marie Rykkelid, Helga Marie Wennberg, Elin Richardsen, Sveinung Wergeland Sørbye
Post-Conization HPV Vaccination and Its Impact on Viral Status: A Retrospective Cohort Study in Troms and Finnmark, 2022. Pathogens (Basel, Switzerland) 13 (5) (2024)
Marte Pettersen Mikalsen, Gunnar Skov Simonsen, Sveinung Wergeland Sørbye
Impact of HPV Vaccination on the Incidence of High-Grade Cervical Intraepithelial Neoplasia (CIN2+) in Women Aged 20-25 in the Northern Part of Norway: A 15-Year Study. Vaccines 12 (4) (2024)
Amir Rad, Sveinung Wergeland Sørbye, Sweta Tiwari, Maja-Lisa Løchen, Finn Egil Skjeldestad
Risk of Intraepithelial Neoplasia Grade 3 or Worse (CIN3+) among Women Examined by a 5-Type HPV mRNA Test during 2003 and 2004, Followed through 2015. Cancers 15 (12) (2023)
Finn Egil Skjeldestad, Sveinung Wergeland Sørbye
May Women with a Negative Co-Test at First Follow-Up Visit Return to 3-Year Screening after Treatment for Cervical Intraepithelial Neoplasia? International journal of environmental research and public health 20 (6) (2023)
Amir Rad, Sveinung Wergeland Sørbye, Tormod Brenn, Sweta Tiwari, Maja-Lisa Løchen, Finn Egil Skjeldestad
13-Type HPV DNA Test versus 5-Type HPV mRNA Test in Triage of Women Aged 25-33 Years with Minor Cytological Abnormalities-6 Years of Follow-Up. International journal of environmental research and public health 20 (5) (2023)
Sveinung Wergeland Sørbye, Bente Marie Falang, Matthys H Botha, Leon Cornelius Snyman, Haynes van der Merwe, Cathy Visser, Karin Richter, Greta Dreyer
Enhancing Cervical Cancer Prevention in South African Women: Primary HPV mRNA Screening with Different Genotype Combinations. Cancers 15 (22) (2023)
Amir Rad, Sveinung Wergeland Sørbye, Tormod Brenn, Sweta Tiwari, Maja-Lisa Løchen, Finn Egil Skjeldestad
13-Type HPV DNA Test versus 5-Type HPV mRNA Test in Triage of Women Aged 25-33 Years with Minor Cytological Abnormalities-6 Years of Follow-Up. International journal of environmental research and public health 20 (5) (2023)
Finn Egil Skjeldestad, Sveinung Wergeland Sørbye
May Women with a Negative Co-Test at First Follow-Up Visit Return to 3-Year Screening after Treatment for Cervical Intraepithelial Neoplasia? International journal of environmental research and public health 20 (6) (2023)
Amir Rad, Sveinung Wergeland Sørbye, Tormod Brenn, Sweta Tiwari, Maja-Lisa Løchen, Finn Egil Skjeldestad
13-Type HPV DNA Test versus 5-Type HPV mRNA Test in Triage of Women Aged 25-33 Years with Minor Cytological Abnormalities-6 Years of Follow-Up. International journal of environmental research and public health 20 (5) (2023)
Finn Egil Skjeldestad, Sveinung Wergeland Sørbye
May Women with a Negative Co-Test at First Follow-Up Visit Return to 3-Year Screening after Treatment for Cervical Intraepithelial Neoplasia? International journal of environmental research and public health 20 (6) (2023)
Amir Rad, Sveinung Wergeland Sørbye, Sweta Tiwari, Maja-Lisa Løchen, Finn Egil Skjeldestad
Risk of Intraepithelial Neoplasia Grade 3 or Worse (CIN3+) among Women Examined by a 5-Type HPV mRNA Test during 2003 and 2004, Followed through 2015. Cancers 15 (12) (2023)
Khalid Al-Shibli, Hiba Abdul Latif Mohammed, Ramona Maurseth, Mikkel Fostervold, Sebastian Werner, Sveinung Wergeland Sørbye
Impact of HPV mRNA types 16, 18, 45 detection on the risk of CIN3+ in young women with normal cervical cytology. PloS one 17 (11) (2022)
Christian Børde Arkteg, Sveinung Wergeland Sørbye, Lene Buhl Riis, Stig Manfred Dalen, Jon Florholmen, Rasmus Goll
Real-life evaluation of histologic scores for Ulcerative Colitis in remission. PloS one 16 (3) (2021)
Oddmund Nestegard, Kay-Martin Johnsen, Sveinung Wergeland Sørbye, Fred-Arne Halvorsen, Tor Tønnessen, Eyvind J Paulssen, Kjetil K Melby, Rasmus Goll, Jon Florholmen
Clinical characterization of Helicobacter pylori infected patients 15 years after unsuccessful eradication. PloS one 15 (9) (2020)
Bjørn Westre, Anita Giske, Hilde Guttormsen, Sveinung Wergeland Sørbye, Finn Egil Skjeldestad
Quality control of cervical cytology using a 3-type HPV mRNA test increases screening program sensitivity of cervical intraepithelial neoplasia grade 2+ in young Norwegian women-A cohort study. PloS one 14 (11) (2019)
Sveinung Wergeland Sørbye, Silje Fismen, Tore Jarl Gutteberg, Elin Synnøve Mortensen, Finn Egil Skjeldestad
Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study. BMJ open 6 (8) (2016)